Laurus Labs Ltd.
Snapshot View

338.35 -0.20 ▼-0.1%

09 February 2023, 03:18:55 PM
Volume: 871,653

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.lauruslabs.com
Market Cap 18,168.70 Cr.
Enterprise Value(EV) 20,236.44 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 17.04 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 19.80 Trailing Twelve Months Ending 2022-12
Industry PE 30.86 Trailing Twelve Months Ending 2022-12
Book Value / Share 74.98 Trailing Twelve Months Ending 2022-12
Price to Book Value 4.50 Calculated using Price: 337.30
Dividend Yield 0.59 Period Ending 2022-03
No. of Shares Subscribed 53.87 Cr. 538,650,925 Shares
FaceValue 2
Company Profile
Laurus Labs offers broad and integrated portfolio of Active Pharma Ingredients (API) including intermediates, Generic Finished dosage forms (FDF) and Contract Research services to cater to the needs of the global pharmaceutical industry. Their major focus areas include anti-retroviral, Hepatitis C and Oncology drugs.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.06%
1 Week
-0.19%
1 Month
-10.73%
3 Month
-24.94%
6 Month
-38.60%
1 Year
-35.69%
2 Year
-6.20%
5 Year
+228.72%
10 Year
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 33.42 14.47 18.65 18.12 11.97 6.19 15.39 45.15 28.05
Return on Capital Employed (%) 19.96 13.74 16.35 16.52 13.68 8.22 14.14 39.82 25.97
Return on Assets (%) 7.64 4.31 6.61 8.05 6.04 3.00 7.34 20.87 13.09

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 358 722 857 1,330 1,483 1,558 1,770 2,598 3,351 3,763
Non Curr. Liab. 204 364 428 132 174 295 214 693 928 943
Curr. Liab. 711 802 884 1,121 1,307 1,424 1,692 2,457 2,681 3,340
Minority Int. 3 8 9
Equity & Liab. 1,273 1,888 2,169 2,584 2,964 3,278 3,676 5,751 6,968 8,056
Non Curr. Assets 697 1,024 1,166 1,444 1,716 1,815 1,864 2,676 3,623 3,883
Curr. Assets 575 862 1,003 1,140 1,248 1,463 1,812 3,075 3,345 4,173
Misc. Exp. not W/O 2 2
Total Assets 1,273 1,888 2,169 2,584 2,964 3,278 3,676 5,751 6,968 8,056

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 1,160 1,327 1,778 1,905 2,056 2,292 2,832 4,814 4,936 6,084
Other Income 9 34 4 33 29 16 6 24 15 6
Total Income 1,169 1,361 1,782 1,938 2,085 2,308 2,838 4,837 4,951 6,090
Total Expenditure -956 -1,131 -1,415 -1,497 -1,643 -1,936 -2,267 -3,263 -3,513 -4,381
PBIDT 212 229 367 441 443 372 570 1,574 1,438 1,709
Interest -59 -101 -111 -100 -80 -88 -90 -68 -102 -143
Depreciation -33 -62 -86 -106 -125 -164 -187 -205 -251 -303
Taxation -24 2 -35 -44 -70 -26 -38 -317 -251 -342
Exceptional Items
PAT 97 68 134 191 168 94 255 984 832 921
Minority Interest 0 -5 -2
Share Associate 0 0 -1 0 -1
Other Related Items
Consolidated Net Profit 97 68 134 190 168 94 255 984 828 918
Adjusted EPS 13 9 17 4 3 2 5 18 15 17

Cash Flow View Details >>

Particulars 9 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 121 -65 182 332 342 298 347 733 911
Cash Fr. Inv. -312 -397 -312 -289 -384 -253 -221 -941 -914
Cash Fr. Finan. 203 486 103 -54 42 -45 -128 255 30
Net Change 12 24 -27 -10 1 0 -1 47 27
Cash & Cash Eqvt 15 40 13 2 3 3 2 48 75

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 28.76 27.45 27.30 27.30 27.27 27.27 27.27 27.27 27.20
Public 71.24 72.55 72.70 72.70 72.73 72.73 72.73 72.73 72.80
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 15.76 1.15 0.00 0.00 0.00 0.00 0.00 0.04 0.04

Announcements View Details >>

Wed, 08 Feb 2023
Copy of Newspaper Publication
Laurus Labs Limited has informed the Exchange about Copy of Newspaper Publication
Tue, 07 Feb 2023
Analysts/Institutional Investor Meet/Con. Call Updates
Laurus Labs Limited has informed the Exchange about Schedule of meet
Tue, 07 Feb 2023
Copy of Newspaper Publication
Laurus Labs Limited has informed the Exchange about Copy of Newspaper Publication

Technical Scans View Details >>

Wed, 08 Feb 2023
Closing Above Previous High Closing Above Previous High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months
High Decrease in 6 Months High Decrease in 6 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 243,148.61 1,006.60 -0.6%
Cipla Ltd. 83,886.47 1,020.50 -1.8%
Dr. Reddy's Laboratories Ltd. 74,707.50 4,487.55 0.0%
Divi's Laboratories Ltd. 74,340.49 2,826.70 +1.0%
Apollo Hospitals Enterprise Ltd. 63,077.61 4,384.90 -0.1%
Torrent Pharmaceuticals Ltd. 52,675.65 1,540.05 -1.1%
Zydus Lifesciences Ltd. 47,993.66 474.45 +0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 57.66 1,006.60 -0.6%
Cipla Ltd. Consolidated 2022-12 31.80 1,020.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.50 4,487.55 0.0%
Divi's Laboratories Ltd. Consolidated 2022-12 31.01 2,826.70 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 75.13 4,384.90 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 63.19 1,540.05 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.29 474.45 +0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.39 1,006.60 -0.6%
Cipla Ltd. Consolidated 2022-12 3.70 1,020.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.39 4,487.55 0.0%
Divi's Laboratories Ltd. Consolidated 2022-12 5.98 2,826.70 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.54 4,384.90 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.24 1,540.05 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.78 474.45 +0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,006.60 -0.6%
Cipla Ltd. Consolidated 2022-03 0.04 1,020.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,487.55 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,826.70 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,384.90 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,540.05 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 474.45 +0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.60 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,020.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,487.55 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.70 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,384.90 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,540.05 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 474.45 +0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,006.60 -0.6%
Cipla Ltd. Consolidated 2022-03 13.10 1,020.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,487.55 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,826.70 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,384.90 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,540.05 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 474.45 +0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,006.60 -0.6%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,020.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,487.55 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,826.70 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,384.90 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,540.05 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 474.45 +0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,006.60 -0.6%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,020.50 -1.8%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,487.55 0.0%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,826.70 +1.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,384.90 -0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,540.05 -1.1%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 474.45 +0.1%

FAQ's On Laurus Labs Ltd.

What is Laurus Labs share price?

Can I buy Laurus Labs shares now?

What is the Dividend Yield of Laurus Labs?

What is the Market Cap of Laurus Labs?

What are the key metrics to analyse Laurus Labs?

What is the 52 Week High and Low of Laurus Labs?

What is the trend of Laurus Labs share price?